Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia

NCT04296214 is registered in ClinicalTrials.gov with Grupo Cooperativo de Hemopatías Malignas as lead sponsor.

NCT NCT04296214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04296214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Lead sponsor
Grupo Cooperativo de Hemopatías Malignas
Phase
Observational
Overall status
Withdrawn
Start date
January 1, 2020
Completion date
March 15, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, myelodysplastic syndromes